rufinamide
NDC 68462-714, rufinamide, tablet, film coated, from Glenmark Pharmaceuticals Inc., USA.
- Product NDC
- 68462-714
- Status
- Listed
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205075
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68462-714 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RUFINAMIDE400 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68462-714-05 | 68462071405 | 500 TABLET, FILM COATED in 1 BOTTLE (68462-714-05) |
| 68462-714-08 | 68462071408 | 120 TABLET, FILM COATED in 1 BOTTLE (68462-714-08) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/da9ee326-a383-4d46-9d4e-fcc2be3d2680NADAC price for package 68462071408
GET /v1/drugs/nadac/68462071408
Use it
Look up 68462-714 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68462-714 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68462-714. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.